As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended September 30, 2026.

(Q2 Un-audited): As per consolidated life revenue account of the company for April to June, 2026, excess of total expenses including claims over total income (deficit) was BDT 37.72 million as against excess of total expenses including claims over total income (deficit) of BDT 158.90 million in the corresponding previous period of 2025. Whereas as per consolidated life revenue account of the company for January to June, 2026, excess of total expenses including claims over total income (deficit) was BDT 26.95 million as against excess of total expenses including claims over total income (deficit) of BDT 319.46 million in the corresponding previous period of 2025. Balance of Life Insurance Fund was BDT 15,238.04 million as on June 30, 2026 as against BDT 15,722.22 million as on June 30, 2025 resulting a net decrease of BDT 484.18 million. Consolidated NOCFPS was Tk. 10.49 as on June 30, 2026 as against Tk. 15.21 as on June 30, 2025.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 28, 2026 at 3:00 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.

Trading of the shares of the company will resume on 21.07.2026.

Trading of the shares of the company will remain suspended on record date i.e., 20.07.2026.

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 16.07.2026 to 19.07.2026 and trading of the shares will remain suspended on record date i.e., 20.07.2026.

The auditor of the company has given the Basis for Qualified Opinion and Other Matters paragraph in the auditor's report for the year ended December 31, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/Popular%20Life%20Insurance%20Company%20Limited.pdf

Refer to their earlier news disseminated by DSE today i.e., 28.06.2026 regarding Q1 Financials, the company has further informed that, as per consolidated life revenue account of the company for January to March, 2026, excess of total income over total expenses including claims (surplus) was BDT 10.77 million as against excess of total expenses including claims over total income (deficit) of BDT 160.56 million in the corresponding previous period of 2025. (Continuation news of POPULARLIF): Balance of Life Insurance Fund was BDT 15,275.86 million as on March 31, 2026 as against BDT 15,947.74 million as on March 31, 2025 resulting a net decrease of BDT 671.88 million. NOCFPS was Tk. 27.66 for January-March 2026 as against Tk. 30.46 for January-March 2025. Please ignore the previous news regarding the same.

As per consolidated life revenue account of the company for the period ended March 31 2026, the total income was Tk. 1,001,371,036.00; total expense was Tk. 990,598,606.00 and Life Fund was Tk. 10,772,430.00 as against Tk. 1,020,665,558.00; Tk. 1,181,223,306.00 and Tk. (160,557,748.00) for the period ended March 31, 2025. NOCFPS was Tk. 27.66 for January-March 2026 as against Tk. 30.46 for January-March 2025.

The Board of Directors has recommended 20% Cash Dividend for the year ended December 31, 2025. Date of AGM: 22.09.2026, Time: 12:00 PM, Venue/ Mode: Virtually by using Digital Platform through the link: https://popularlifeins.bdvirtualagm.com. Record Date: 20.07.2026. The Company has also reported EPS of Tk. 1.47, NAV per share of Tk. 78.10 and NOCFPS of Tk. (18.86) for the year ended December 31, 2025 as against Tk. 2.53, Tk. 89.01 and Tk. (3.45) respectively for the year ended December 31, 2024.